Sparking Researcher Community Involvement: Karger’s New Ambassadors Program

It’s not easy being a researcher – no elaborate studies are needed to prove that! Besides the actual pursuit of science, researchers are expected to learn how to publish and review articles, network, and understand trends as well as comprehend the whole knowledge ecosystem. They carry a lot on their shoulders, and it’s all essential to optimizing their efforts and careers.

Our new Karger Ambassadors Program aims to give researchers – especially Early Career Researchers – a helping hand in much of that labor that takes place outside the lab. Recognizing and showing appreciation for researchers’ excellence and efforts is important to us, as is supporting structures that let researchers thrive.

Among other activities, ambassadors will get to liaise with experts in our network, develop leadership skills, and gain insights into how communicating science really works. For example, many authors feel apprehensive about publishing Open Access, which can seem complex but can also lead to vastly larger readership. Or they might not be aware of handy resources that break down how peer review works or why research integrity matters so much. We want to shed light on all this by teaming with ambassadors.

Ambassadors will not only have the opportunity to expand their knowledge, but will also pay it forward to their peers by representing Karger and sharing what they learn with their cohorts. While we gladly welcome ambassadors at all levels of experience, we anticipate participation especially benefitting Early Career Researchers, including students, PhD candidates, postdocs and others in earlier stages of their careers.

Not only researchers benefit; the program is just as valuable for us. We look forward to the ambassadors bettering our understanding of research communities’ needs and helping us build relationships.

If you think you or anyone you know could thrive in a role as an ambassador, please write us at ambassador@karger.com to find out more.

Driving the Change with Subscribe to Open

At Karger, it is no news that we are Open for Open. And we have just added yet another layer of openness to our publishing models in the form of Subscribe to Open (S2O). With this initiative, we are offering our communities an alternative Open Access model, piloted in 2023 with two journals in the Neurology and Neurosciences portfolio: Developmental Neuroscience and Pediatric Neurosurgery.

What is S2O?

S2O is a sustainable publishing model that converts subscription-based journals to Open Access (OA) without some of the barriers that other models may present. That means research becomes openly available online once a renewal target has been met. It is yet another way to bring OA to all, which is good for authors and readers alike. For librarians, this is great news: besides providing their researchers with the opportunity to publish OA, S2O relies on existing library subscription budgets and procurement processes so there is no need to establish new systems. At the same time, readers benefit from a vast array of research that might otherwise be gated. The model was originally created by Annual Reviews, which also spearheaded the S2O Community of Practice.

How Does S2O Work?

Essentially, journals are OA for an entire year once a certain number of subscriptions has been reached. S2O-based publishing costs are sustained by subscriptions, leveraging existing subscription bases, funds, and infrastructure. Simply put: If subscriptions are renewed to a target level, we will make that year’s volume completely free of barriers to publish, read, share and re-use. With easier access to a broader readership, that means more reach, visibility and impact for authors. Even better – all authors will be able to publish without paying any fees if that volume becomes OA.

It’s important to note that the subscription process will be repeated every year, so future volumes may remain fully OA or return to the hybrid model (subscription-based with a paid option to publish articles OA) depending on subscription levels. Working with our stakeholders, we hope to reach subscription levels that will enable ongoing OA.

Bridging the Gaps Towards an Open Future

We are continuously exploring different ways of empowering researchers, policy makers and others to easily read and share trusted, peer-reviewed science through different OA models. Very often, authors need to comply with OA mandates and encounter barriers in the form of high Article Process Charges. Along with the many other ways we drive the transition to a more open research ecosystem, with S2O, we hope to bring together different parts of this puzzle and solve them together: libraries and institutes can play a key role in unlocking journals, authors have the possibility to publish APC-free, and Karger acts as the bridge between the present and future of OA.

Third VIA Edition: Exclusive Interview with Juror Stephanie Dawson

The Vesalius Innovation Award  (VIA) is one way we at Karger spark innovation in health sciences. We see it as a dual opportunity: for startups with great ideas it’s a chance to receive mentoring, exposure and a cash award; and for us, we get to discover new perspectives and support progress across the knowledge cycle as well as in Open Science. 

stephanie dawsonOne of our VIA jurors –  Stephanie Dawson, CEO of discovery platform  ScienceOpen – shared insights from her broad and deep experience in the following interview. We’re thrilled she could take some time with us to reflect on topics such as the  importance of Open Science and what’s needed to drive it forward. Vesalius Innovation Award applicants will also find some valuable guidance. Read on!

Before we turn to the Vesalius Innovation Award and Open Science, can you briefly introduce yourself? You’ve had a broad education in an unusual combination – biology, then languages and literature – on two continents. Tell us more about the path that has led to being the long-standing CEO of ScienceOpen in Berlin. And what are you focusing on now?

I have really always been drawn both to the natural world and literary representations of it. I grew up on a ranch in northern California and was quite sure that I was going to be a cowgirl or veterinarian, but I was also a voracious reader and a bit of a romantic. So at Yale, I studied biology while also taking many courses in literature and art. After college, I worked in a genetics lab at the prestigious Fred Hutchinson Cancer Researcher Center in Seattle. But when I developed an allergy to fruit flies, I switched fields and got my PhD in German literature from the University of Washington. When I settled with my German husband in Berlin, I discovered that academic publishing was an environment that valued my eclectic experiences and provided space to combine my passion for science and the written word. As the CEO of ScienceOpen I have had the opportunity to explore scholarly communication in a digital environment. My current focus is on Open Access publishing, preprints, open peer review, community curation, metadata enrichment, and alternative metrics.

We’re so excited to have you on the VIA jury again. Before we look at VIA 2022 and beyond, I’m curious about your experience as a juror last year. What has had a lasting impact on you? Does anything stand out from the entrants, winners or overall process?

Being part of the VIA jury last year was really a highlight for me. I deeply enjoyed the interaction with the other jurors and was able to refresh some connections and make new ones. I am often so busy with my own projects that I sometimes neglect to step back for a wider industry perspective. In my experience, start-ups spring up around systematic pain-points, so it is naturally very important to keep an eye on what is new or growing fast. I especially enjoyed working with the teams at NestedKnowledge and CiteAb as we are addressing some of the same issues around metadata.

For participating startups in 2022, the focus of the VIA has expanded to include Open Science. You, along with ScienceOpen, have long championed Open Science. How would you define the crux of Open Science – think elevator pitch? And why do you consider it to be so important?

Open Science encompasses the entire workflow of scientific inquiry – from hypothesis through experiment and data collection to the communication of results. Open and interoperable systems at every level can increase the speed, breadth and inclusivity of knowledge generation. But currently only a fraction of the published literature is available open access to a global audience. An even smaller fraction of the scientific data is available in open repositories in machine-readable formats or code available as open source. Open methods and notebooks, open peer review and educational resources are all important in making information more widely accessible. Working in sync can produce powerful results. But these digital processes are expensive, so it is essential to develop new ways of creating value, which is where the start-ups pitching for the VIA award come in.

What do you think needs to be prioritized and actioned among various communities to help Open Science progress further?

We need to continue to prioritize interoperability and machine-readability at each step of the process. Giving global readers access to an Open Access article in a pdf form is great, but Open Science requires that the content can be aggregated, ingested, analyzed and read by machines. One of the richest and most powerful repositories in the world is the PubMed Central (PMC) Open Access Data Subset that is freely available for researchers, developers and start-ups to read, mine, experiment with and build on. This is a big, expensive collective undertaking and highlights the essential role of funders in funding and maintaining open infrastructure. One of the unique features of PMC is that all content is not only open access with a machine-readable license, but also available in full-text as tagged XML in a single JATS standard.

What role do publishers play regarding Open Science?

The publishing industry has played a crucial role in not only ensuring scientifically valid content but also creating high-quality digital files that use standardized persistent identifiers for everything from author names to institutions to data sets. A free pdf on a website is open access but a full-text XML document in a repository of 5 million articles is Open Science. The start-ups pitching for the VIA are all beneficiaries of Open Science in one way or another.

What other communities, if any, need to be involved more?

I believe that the community of digital start-ups plays an important role in creating value and showcasing the impact of Open Science, which encourages authors, institutions, publishers and funders to invest in the necessary technology to present the results of academic research in interoperable and machine-readable formats. And that is of course why I am excited to be on the VIA jury.

How would you rate the progress of Open Science in health science and scholarly publishing communities so far? How does the current state of affairs compare with what you would have expected or hoped for 10 years ago?

I will admit that 10 years ago, I believed the move to open access and open data, particularly in the health and life sciences, would be faster and more comprehensive, just because they provide so many advantages to authors and researchers. But now, I think that the slow progress is, in part, a result of the increasing demands of Open Science on the technological infrastructure. I no longer expect a disruptive open access revolution, but rather a continual process of building a rich shared digital knowledge base that we can all participate in and draw on.

The application period for the 2022 VIA is still open, and we can’t wait to be dazzled by ideas presented at the live pitch session. For any start-ups still working on their applications for this or future years, do you have any advice?

I’m really excited to see this year’s applications. My one piece of advice is to be open and realistic about where you are in the process of product development in your live pitch. We’re interested in ideas at all stages but may have different expectations depending on how far a product has progressed. And of course, share your passion – it can be infectious. I am really looking forward to being a juror again!

 

Dr. Stephanie Dawson, CEO of ScienceOpen, has degrees in biology and German literature and a background in STM publishing from De Gruyter publishers. She was part of the founding team of ScienceOpen in 2013 and has been exploring topics around Open Science ever since.

Signing DORA and Overcoming the Tyranny of ‘Prestige’ in Research Assessment

Some feel that potential in research communications is stifled by the tyranny of ‘prestige’ when it’s measured solely by journal impact factor. The Declaration on Research Assessment (DORA) and its supporters – including Karger Publishers – are promoting measures to enable a more balanced system.   

When we signed DORA early this year, we formalized our ongoing dedication to best practices and wide-reaching support of the research community. DORA, a global initiative launched in 2012, came out of the need to improve the way researchers and research outputs are evaluated. It aims to raise awareness, facilitate implementation, catalyze change and improve equity in scholarly communications. Nearly 22,000 organizations and individuals have signed to date.

To this end, DORA guides publishers, research funders, institutions, researchers and organizations that provide metrics for publications with an array of recommendations. The first is this: “Do not use journal-based metrics, such as Journal Impact Factors, as a surrogate measure of the quality of individual research articles, to assess an individual scientist’s contributions, or in hiring, promotion or funding decisions.” What exactly is the problem with impact factor? It can be useful, but overdependence on impact factor as a criterium to assess individuals and their work can create a vicious cycle.

Put very simply, if career-impacting decisions are made based on the impact factor of the publication in which a job seeker or grant applicant has published, a number of consequences may ensue: Authors may feel pressure to prioritize impact factor above all else when seeking a venue to communicate their work – and that can come at the expense of choosing an Open Access journal or another well-suited journal just because it has a lower impact factor, for example. Or, pressured to heighten impact factor, journals may overlook articles with valuable insights because they’re less likely to reap ‘impact’-boosting citations. All this can all hamper wider adoption of Open Access and Open Science practices, which are at the core of scientific principles.

We as a publisher may not be able fundamentally to change the situation. But we can support our stakeholders advocating for change and ensure we provide publishing conditions that are conducive to a dynamic, equitable research ecosystem. Here’s how we practice DORA’s recommendations for publishers:

  • We have mindfully reduced emphasis on journal impact factor as a promotional tool. While impact factor is important information, we aim to convey it in context.
  • We communicate a range of metrics on our website at an article and journal level, of which impact factor is just one. This presents a thorough, balanced snapshot of our journals.
  • We strongly encourage responsible authorship practices and guide authors so they understand what these are. Our published articles include information about each authors’ specific contributions.
  • We facilitate re-use of reference lists in research articles and support the Initiative for Open Citations (I4OC), making citation metadata openly available via Crossref.
  • We ask authors to adhere to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals from the International Committee of Medical Journal Editors (ICMJE). That includes guiding them to “provide direct references to original research sources when possible” and we generally do not strictly limit the number of references in research articles, particularly in online publications without print constraints.

The challenges of research assessment appear to be deep-seated, and it has proven rather difficult to move the needle. But we join with DORA and so many members of the research community to raise awareness and work toward a more equitable, open ecosystem.

Open Science: Fighting Faster, Smarter and More Equitably against Covid-19

There have been heated debates about how exactly to deal with the recent Covid-19 pandemic. But one thing most people can agree on (besides being ecstatic if/when this is fully behind us) is that the benefits of Open Science have never been clearer.  

Open Science (OS) describes a broad set of activities and practices aimed at making scientific processes and output more collaborative, accessible, transparent and effective. Through technological and cultural change, Open Science can enhance the ways research, education and innovation are carried out and disseminated via digital tools, networks and media.  

Currently, the most widespread element of Open Science within scholarly communications is Open Access (OA). Open Access makes published articles free to read, share and re-use in accordance with the license applied. Often, Open Access publishing is financed via a per-article payment from the author or author’s research funder, as opposed to the model under which readers pay subscription fees in exchange for access. However, the crisis made it crucial to remove all barriers to access. So we made hundreds of articles related to Covid-19 immediately and freely available, regardless of the model they were published under, and signed a statement affirming our commitment to doing so. Even as the intensity of the pandemic is seeming to abate, the articles remain free, with about 100 of them fully Open Access. (Karger Open Access articles are published under a Creative Commons license, which requires the authors’ signatures. It is not possible to make previously published articles retroactively Open Access, and authors do not always sign this agreement.)    

Preprints and Open Data

Two other Open Science elements that have gained traction are preprints – essentially the manuscript of an article before it is submitted to a journal and thus before peer review – and open data, with authors making their underlying research data freely available, usually via a specialized repository. Both have been instrumental to advancing knowledge about the Coronavirus and how it affects human health, its transmission, prevention and more.  

While peer review helps ensure research findings presented in scientific articles have been scrutinized and approved by experts in the field, the process of peer review and publication can be lengthy. Preprints allow scientists to share new findings as quickly as they can write them so they can reach other scientists, policy makers, and the public. Our policies support authors who choose to share preprints before submission, and we collaborate with the well-known preprint servers medRxiv and bioRxiv to allow authors to submit papers to some of our journals via an easy transfer of their preprint.  

The Danger of Infodemics

That said, preprints should be considered with caution, as we saw amid the desperation for news and cures: Preprints helped to swiftly disseminate urgently needed information, but they were also used by some to feed an “infodemic” of sometimes false or misinterpreted information that even hindered efforts at times. The information they contain is not (yet) peer reviewed – that is, vetted by experts. Journalists and others in the public may not emphasize or recognize that the conclusions are tentative and may even be disproven in the future. And by the time any findings in preprints might be refuted, it’s too late: They may have spread across traditional and social media, with people all over the world acting on the advice. The Covid-19 pandemic produced some notorious situations with preliminary information being proven wrong or at least inconclusive. That’s a perfectly normal course of events in research, and getting feedback from other scientists can be one of the benefits of posting a preprint. But the early, unconfirmed nature of preprints can harm individuals if they act on the early findings and either doubt or never see subsequent reports with different recommendations.  

Open and FAIR

Informing the public that preprints contain preliminary, unreviewed information and educating science journalists about their use may help. But another aspect of Open Science, open data, can also help by allowing other scientists to check the preliminary studies. Research data is usually defined as the underlying evidence needed to validate and replicate findings reported in an article. If that data is open and “FAIR” (Findable, Accessible, Interoperable, Reusable), others can try to validate and reproduce it. Research funders and institutions increasingly require authors to make their data open, and we have introduced comprehensive guidance for authors on how and why to share their data, which we strongly encourage at all times. 

Some of our actions during the pandemic may not be strictly classified as Open Science, but they share the same spirit of striving to empower rapid, unrestricted knowledge exchange to stabilize public health.  

For example:  

  • Despite the sudden volatility in everyone’s work environment, we processed a huge surge of submitted articles, in particular related to Covid-19, to maintain the timely flow of information. 
  • We continue to publish and curate pertinent articles across all our publications and platforms, from our virology-related journals to The Waiting Room blog. This content covers everything from helping Coronavirus patients with co-morbidities, to diagnosis, to societal and mental-health impacts, to olfactory disorders and treatment.   
  • We made our Fast Facts medical handbook series free to access online – and will keep it free beyond the pandemic. We also created free Fast Facts eLearning courses to help maintain education and engagement when people were restricted from interacting live.   
  • We granted more access to non-Open Access content for institutions in need.  
  • We upgraded subscription access, expanded licenses and added features for a host of customers and ePartners.
  • We gave free access to especially relevant education courses 
  • We created many more free webinars and online training sessions. 

At the core of what we do is connecting and advancing health sciences throughout the entire knowledge cycle. Open Science practices and other support make this as efficient and beneficial as possible for the greatest number of people. We are grateful for the many ‘front line workers’, scientists, and policy makers who have worked to improve all outcomes in the face of the pandemic, and we’re rather proud of the contribution we could make to the global fight against Covid-19.    

Further Reading: Scholarly Communication in Times of Crisis: The response of the scholarly communication system to the COVID-19 pandemic by the Research on Research Institute (RoRI) 

Transforming to Open Access with Transformative Journals

Working to advance Open Access (OA), an essential element of Open Science, can feel like solving a Rubik’s Cube: the end goal is clear but the way there isn’t always. Working through the challenges requires deliberation and some openness to trying different possible solutions. One of these is the Transformative Journal.

Karger introduced the Transformative Journal, sometimes called a TJ, to our program in 2021. While our seven Transformative Journals certainly are not the only piece needed to solve the OA puzzle, they hold a lot of promise to move OA forward in the right direction.

To understand what Transformative Journals are, it helps to have in mind a definition of OA and some of the main types.

  • Gold Open Access: The version of record (final, published version) of articles is permanently free to read, share and re-use. Often, publication costs are covered by an Article Processing Charge (APC), which may be paid by a funder, institution, or author.
  • Open Access Journal: Journals that publish only Open Access articles.
  • Hybrid Journal: Originally subscription only, these journals let authors choose whether to make their articles OA through payment of a fee (by the institution, research funder, or author) or publish them under the subscription model.

(There are more types of OA and terminology. We encourage you to have a look at the explanations on our Open Access pages.)

In these terms, Transformative Journals are essentially hybrid journals. But Transformative Journals don’t merely offer authors a choice – they proactively encourage publication of more OA articles. The idea is to make OA publishing even easier and fast-track a sustainable transition to OA. When Transformative Journals reach a certain share of OA articles (75% OA), they are designated to “flip” to OA, i.e. convert to the OA business model.

Plan S

Transformative Journals started taking hold as one possible stepping stone to a more open future when Coalition S, a group of research funders, recognized them as a way to help authors comply with certain mandates under Plan S. Plan S is a set of stringent, wide-reaching, complicated and somewhat controversial requirements intended to promote OA, though they also present challenges to authors and publishers. To comply with the mandates, Coalition S-funded authors must publish their articles as OA under certain terms. One option is to publish in an OA journal and another is to make the author’s manuscript freely available in a repository. Or, authors may publish under a transformative arrangement – meaning either in a hybrid journal that is covered by a special agreement (known as a Transformative Agreement) with their institutions, or in a Transformative Journal.

One of our missions is to support authors in every way possible, which is why we help them comply with virtually every OA mandate – so facilitating compliance with the Plan S mandates is one great benefit of our Transformative Journals. Another benefit is the way they address some of the above-mentioned challenges of advancing OA.

Barrier-Free Publishing

For one, there’s the question of how to pay for OA publishing. OA makes important scientific knowledge rapidly available to all, a benefit that has become even more obvious since the pandemic began. But the services that publishers provide (such as managing peer review, editing, and ensuring discoverability) entail costs that must be paid for. In lieu of subscription income, those costs may be covered by APCs, but that can create new barriers for the many authors who lack funding. Transformative Journals do not provide a long-term solution to that problem, but – in a transitional phase – they do allow those who can pay for it to publish OA; and those who cannot may continue to publish under the subscription route.

That leads to another challenge that Transformative Journals help navigate as we aim for a sustainable move to more open research: Even authors who have the means to publish OA don’t always choose to. There’s been much scrutiny of the reasons, and usually it comes down to this: Whether they understand the advantages of OA or not, when it comes to submitting their papers, authors base their decisions on other factors, such as the community of researchers they will reach or the journal’s prestige, typically measured by impact factor (IF).

Sustainable Transition

While efforts such as the San Francisco Declaration on Research Assessment (DORA) aim to lessen the grip that the IF holds on researchers, funders, institutions and journals, Transformative Journals in the meantime allow us to meet authors where they are. We can make OA more attractive and efficient and show authors the benefits of OA, while still offering the freedom to publish in the journal that most fits their needs. This is not only for the authors’ sake, but is also crucial to making the transition to OA and OS truly sustainable. We have flipped over a dozen journals from subscription to OA in the last few years and hope to flip more. But flipping journals if authors aren’t keen to publish OA is destabilizing rather than sustainable.

At the same time, we recognize that moving to an open research world is complex and lacks a quick fix. So we continue to explore alternative solutions even as we work on Transformative Journals, flipping, launching new OA journals and Transformative Agreements – in addition to adopting policies and innovations that support Open Science. We would welcome your thoughts on Transformative Journals and how the transition to more open research availability and practices can be supported further!

Learn more about Open Access and Open Science.

On Open Access Week: A Newly OA Journal with Vision

Flipping our journal Ophthalmic Research in 2021 has proven to be anything but shortsighted. We kicked off our own Open Access Week with an internal event, a Best-in-Class example, and a pub quiz.  

The journal’s success as one that “flipped” – that is, converted – from the subscription business model to Open Access (OA) shows that OA was clearly the right move, as Editor-in-Chief Dr. Hendrik Scholl told staff during a company  event for International Open Access Week. Dr. Scholl is currently the director of the Institute of Molecular and Clinical Ophthalmology Basel (IOB) and Chair of the Department of Ophthalmology of the University of Basel, with an array of international experience in the field.

Ophthalmic Research Journal for Translational and Clinical Research

Ophthalmic Research

During OA Week, academic and research communities around the world engage with OA, and advancing OA is a major priority for us too. So, for the first time, we hosted our own Karger Publishers community event for OA Week with two parts, both virtual: First, in an informal interview,  Dr. Scholl shared his experiences helping to lead the journal’s transformation into OA. Next, we employees tested our knowledge and learned more about OA and Open Science in a “pub quiz” competition that was beer-free but fun and challenging.

Reaching More Communities through Open Access

OA is a rapidly expanding way of publishing that makes journal articles immediately and permanently free for everyone to read, share and re-use. Limits on commercial re-use or other restrictions may apply depending on the type of license used. To cover publication costs, authors or their research funders or institutions typically cover the costs of publication, in contrast with the subscription model under which readers pay for access. With OA, many more people can read publications much more quickly, to the benefit of individuals, researchers, practitioners, policy-makers and others.

Flipping is one way to speed up the transition to OA. But it can also carry risks – for example, losing authors who submit papers, as Karger Publishers CEO Daniel Ebneter explained while interviewing Dr. Scholl.

But for Ophthalmic Research, just the opposite happened: The journal was handling a high number of submissions during the pandemic, as many academic publications were. As is often anticipated after flipping, submissions indeed dipped, though the dent was manageable – down to roughly pre-pandemic numbers. After only a few months, however, they had ballooned back to near-record levels. “The outcome was excellent,” Dr. Scholl reported.

Not only did submissions rise, but use of the articles, measured in clicks, soared. That was a more anticipated but no less delightful development – evidence that OA can increase the visibility of articles, allowing research to achieve greater impact.

Such visibility was one of Dr. Scholl’s and his colleagues’ top reasons for making the leap to OA. Another was to be a leader in the ophthalmology subject area, in which only about 20% of journals were fully OA. “Flipping to OA would mean we would join that… forefront of journals that would be OA. And we felt that would be a competitive advantage.”

To Flip or Not to Flip? Some Advice

What advice might Dr. Scholl have for leaders of journals who are considering flipping to OA? For one, they should be sure to work with a professional publisher they can rely on, with whom there is a good rapport and teamwork, and that has the experience to handle the technical challenges of flipping.

As for concerns that OA may exclude promising authors who can’t afford Article Processing Charges (APCs) – especially in disciplines with less funding – Dr. Scholl pointed out that publishers may have programs to cover those costs. Our program to waive or discount APCs for authors in need gave him confidence that authors submitting a paper with excellent science will have a fair chance to publish it, he said.

Open communication with associate editors and editorial board members is also crucial, Dr. Scholl emphasized. If everyone understands the vision of greater and quicker visibility and other potential benefits from OA, they can better manage to weather any challenges that may come with flipping.

The Need for Speed – and Peer Review

Taking a step back to consider OA and Open Science more broadly, Mr. Ebneter and Dr. Scholl spoke about the trending use of preprints, which are scientific papers before peer review or editing. While speed is generally very welcome, one drawback is the difficulty for scientists to recognize if what they’re reading is validated data. We, the publisher and journal, provide an extremely valuable service, Dr. Scholl said – we give authors feedback and help them improve their work and moreover we produce articles that are not only nicer and easier to digest thanks to services like editing, but also guaranteed to be validated through peer review.

Learn more about Open Access and Open Science.

Beth Bayley

Beth is Open Science Manager and Open Science Task Force co-lead. Her chief missions are helping drive forward Karger Publishers’ sustainable transition to Open Access, often active in strategy, policy and communications; and otherwise putting into motion steps toward more open scholarly communications. A perfect weekend involves a combination of family, travel, books, comedy and/or theater, and perhaps a walk around the Swiss Alps for good measure.

TOP